BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial

• Published in: BMC ophthalmology Vol. 24; no. 1; pp. 503 - 9
• Main Authors: Siegel, Helena, Merz, Annika, Gross, Nikolai, Bründer, Marie-Christine, Böhringer, Daniel, Reinhard, Thomas, Maier, Philip
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.11.2024; BioMed Central; BMC
• Subjects: Adult; Aged; Automation; Biofilms; Blepharitis; Blepharitis - drug therapy; Blepharitis - therapy; BlephEx™ device; Clinical trials; Cross-Over Studies; Debridement; Debridement - methods; Double-Blind Method; Eye diseases; Eyelid; Eyelid margin care; Eyelids; Eyelids - surgery; Female; Follow-Up Studies; Humans; Inflammation; Male; Medical treatment; Meibomian gland; Middle Aged; Ocular surface; Patient compliance; Patients; Placebo effect; Prospective Studies; Quality of life; Statistical analysis; Tear film; Tears - physiology; Treatment Outcome; Visual acuity; United Kingdom > UK; Tear film; Blepharitis; Ocular surface; BlephEx™ device; Eyelid margin care; Meibomian gland

Blepharitis is a chronic inflammatory condition of the eyelids that affects a large proportion of patients in eye care settings. First-line treatments provide only partial relief for many patients. The BlephEx™ device provides automated eyelid debridement and aims to remove pathogenic biofilms from...